HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jan Ostergren Selected Research

candesartan

11/2011Days alive and out of hospital and the patient journey in patients with heart failure: Insights from the candesartan in heart failure: assessment of reduction in mortality and morbidity (CHARM) program.
6/2010Baseline characteristics and outcomes of patients with heart failure receiving bronchodilators in the CHARM programme.
5/2009Predictors of development of diabetes in patients with chronic heart failure in the Candesartan in Heart Failure Assessment of Reduction in Mortality and Morbidity (CHARM) program.
12/2008Clinical outcomes according to baseline blood pressure in patients with a low ejection fraction in the CHARM (Candesartan in Heart Failure: Assessment of Reduction in Mortality and Morbidity) Program.
11/2008Weight loss and mortality risk in patients with chronic heart failure in the candesartan in heart failure: assessment of reduction in mortality and morbidity (CHARM) programme.
6/2008Impact of diabetes on outcomes in patients with low and preserved ejection fraction heart failure: an analysis of the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) programme.
6/2007Sex differences in clinical characteristics and prognosis in a broad spectrum of patients with heart failure: results of the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) program.
5/2007Renin-angiotensin-system blockade in the prevention of diabetes.
5/2007Prevalence and prognostic impact of bundle branch block in patients with heart failure: evidence from the CHARM programme.
6/2006Resource utilization and costs in the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) programme.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Jan Ostergren Research Topics

Disease

23Heart Failure
11/2011 - 09/2003
8Stroke (Strokes)
11/2008 - 03/2002
6Coronary Disease (Coronary Heart Disease)
11/2008 - 04/2003
5Hypertension (High Blood Pressure)
01/2008 - 07/2004
4Myocardial Infarction
05/2012 - 09/2005
4Hypotension (Low Blood Pressure)
12/2008 - 09/2003
3Peripheral Arterial Disease
03/2014 - 11/2002
3Cardiovascular Diseases (Cardiovascular Disease)
06/2006 - 04/2003
2Proteinuria
04/2012 - 01/2008
2Isolated Systolic Hypertension
04/2012 - 01/2008
2Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left)
04/2012 - 01/2005
2Hyperkalemia
12/2008 - 10/2004
2Left Ventricular Dysfunction
01/2005 - 10/2004
1Lung Diseases (Lung Disease)
06/2010
1Diabetes Mellitus
11/2008
1Weight Loss (Weight Reduction)
11/2008
1Insulin Resistance
05/2007
1Heart Diseases (Heart Disease)
01/2007
1Anemia
02/2006
1Sudden Death
10/2005
1Unstable Angina
10/2005
1Type 2 Diabetes Mellitus (MODY)
05/2005
1Hypercholesterolemia
05/2005
1Cough
09/2003

Drug/Important Bio-Agent (IBA)

21candesartanIBA
11/2011 - 09/2003
8Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA
05/2007 - 03/2002
6Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA
05/2007 - 09/2003
5Amlodipine (Norvasc)FDA LinkGeneric
04/2012 - 09/2005
5Angiotensin Receptor AntagonistsIBA
05/2007 - 10/2004
4CholesterolIBA
05/2012 - 04/2003
4Antihypertensive Agents (Antihypertensives)IBA
04/2012 - 07/2004
4Atenolol (Tenormin)FDA LinkGeneric
11/2008 - 09/2005
4Atorvastatin (Lipitor)FDA Link
12/2006 - 04/2003
4LipidsIBA
12/2006 - 04/2003
3Brain Natriuretic Peptide (Natrecor)FDA Link
03/2014 - 01/2005
3ThiazidesIBA
04/2012 - 09/2005
2HDL CholesterolIBA
05/2012 - 09/2005
2Pharmaceutical PreparationsIBA
12/2008 - 10/2004
2DiureticsIBA
06/2006 - 09/2005
1C-Reactive ProteinIBA
03/2014
1Cystatin CIBA
03/2014
1Apolipoproteins B (ApoB)IBA
05/2012
1Apolipoproteins AIBA
05/2012
1benazepril (Briem)FDA LinkGeneric
04/2012
1Hydrochlorothiazide (Esidrix)FDA LinkGeneric
04/2012
1Insulin (Novolin)FDA Link
04/2012
1Bronchodilator Agents (Bronchodilators)IBA
06/2010
1Dipyridamole (Persantine)FDA LinkGeneric
01/2007
1Angiotensin IIIBA
06/2006
1Peptides (Polypeptides)IBA
06/2006
1Hemoglobins (Hemoglobin)IBA
02/2006
1Drug CombinationsIBA
09/2005
1PerindoprilFDA LinkGeneric
09/2005
1pro-brain natriuretic peptide (1-76)IBA
01/2005
1Mineralocorticoid Receptor AntagonistsIBA
10/2004
1CreatinineIBA
10/2004
1Angiotensin II Type 1 Receptor BlockersIBA
09/2003
1Vasodilator Agents (Vasodilators)IBA
11/2002
1Acetylcholine (Acetylcholine Chloride)FDA Link
11/2002
1Nitroprusside (Sodium Nitroprusside)FDA LinkGeneric
11/2002
1Ramipril (Altace)FDA LinkGeneric
03/2002

Therapy/Procedure

5Therapeutics
01/2008 - 07/2004
1Secondary Prevention
03/2002